Beam Therapeutics

Vice President, Clinical Development

Beam Therapeutics$310K — $400K *
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • MD, DO, or equivalent medical degree with 15+ years of experience, including 10+ years in clinical development.
  • Experience in metabolic or rare diseases is preferred.
  • Previous patient care experience required.
  • Demonstrated success in executing clinical development projects through all drug discovery phases.
  • Proven ability to interact effectively with regulatory authorities.
  • Experience influencing experienced professionals and leading teams.
  • Understanding of commercial strategies is a plus.
  • Capabilities to thrive in a fast-paced, dynamic environment.

Responsibilities

  • Lead the development and refinement of the strategic vision for Beam's metabolic franchise.
  • Implement short- and long-term goals that align with the strategic vision.
  • Provide medical counsel and scientific guidance to cross-functional teams on metabolic therapies.
  • Collaborate with teams to devise integrated clinical and regulatory strategies for product commercialization.
  • Design comprehensive clinical development plans and protocols.
  • Oversee strategic and medical aspects of clinical trials to ensure patient safety and compliance.
  • Mentor and manage a team of clinical scientists and physicians.

Benefits

  • Hybrid work environment with on-site presence in Cambridge required.
  • High visibility role with strategic impact across the organization.
  • Opportunity to influence and drive the growth of the metabolic clinical pipeline.
Full Job Description
Position Overview:

The VP, Clinical Development will serve as the medical lead for base editing gene therapies in our metabolic franchise and represent Beam both internally and externally. The position will report to the EVP, Head of Clinical Development. The candidate will develop the vision, mission, outline the strategies, establish the priorities, create alignment, and have full accountability for Beam's clinical metabolic efforts. The VP of Clinical Development will oversee implementation and maintenance of all metabolic internal clinical development programs and will also have the strategic view and excellence in execution to continue to grow the strength and scope of the internal pipeline, in addition to participating in potential business development opportunities, including additional acquisitions. Importantly, the role will be highly visible requiring effectively communicating the Beam Vision and Values in metabolic diseases to other functional groups and to key external stakeholders.

Responsibilities:
  • Lead efforts to develop, refine a vision for the Beam metabolic franchise strategy in a collaborative environment.
  • Develop and implement near- and long-term goals and objectives that are aligned with the strategic vision.
  • In line with corporate objectives, provide relevant medical counsel and scientific guidance to all teams across Beam that are involved in metabolic therapeutic-related activities.
  • Work with cross-functional teams to develop integrated clinical/regulatory strategies for key initiatives to support the successful registration and commercialization of products for the metabolic therapeutic area.
  • Support cross-functional metabolic teams.
  • Design clinical development plans, target-product profiles and protocols that are aligned to support the integrated clinical/regulatory/commercial strategies for the therapeutic area.
  • Provide strategic and medical oversite of planned and ongoing clinical trials.
  • Ensure high quality clinical development standards with respect to clinical study design, conduct, and oversight of patient safety.
  • Support the Research & Development Leadership Team as well as Business Development as it relates to metabolic research and clinical development activities.
  • Work closely with research teams to develop next gen therapeutic programs.
  • Attend and help prepare material for medical conferences, Regulatory Agency meetings, Advisory Boards and other relevant clinical events as required.
  • Manage and mentor multiple physicians and clinical scientist direct reports.

Qualifications:
  • MD, DO or equivalent ex-US medical degree with 15+ years' experience, 10+ years clinical development experience in industry is a must. Final level and scope of role will be commensurate with experience.
  • Clinical or drug development experience in metabolic diseases and/or rare disease is desirable.
  • Must have previous patient care experience.
  • Demonstrated ability to successfully execute clinical development projects across all phases of drug discovery.
  • Proven track record of successful interactions with regulatory authorities.
  • Demonstrated ability to lead and influence experienced professionals.
  • Experience working with commercial strategies is desirable.
  • Ability to lead in a fast-changing environment.
  • Broad knowledge and exposure across all R&D functions.
  • Deep understanding of clinical/pre-clinical pharmaceutical development.
  • Strategic thinker with strong execution skills.
  • Effective communicator.

Location Requirement:
  • This is a hybrid role; however, this role requires that the candidate(s) live within a reasonable commuting distance to be on site in our Cambridge location several times per week.


The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.

Beam Pay Range

$310,000-$400,000 USD

About Beam Therapeutics

Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines using its proprietary base editing technology. The company's platform allows for precise and efficient editing of single base pairs in DNA and RNA, which has the potential to treat a wide range of genetic diseases. Beam Therapeutics' lead product candidate, BEAM-101, is a potential treatment for sickle cell disease and beta-thalassemia. The company was founded in 2017 and is headquartered in Cambridge, Massachusetts.
Learn more about Beam Therapeutics
Size
341 employees
Market Cap
$2.7 billion
Industry
Net Income
-$126.9 million
Revenue
$20,000
NASDAQ

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Find similar Vice President, Clinical Development jobs: